2024-04-24
04:32 |
|
|
Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk
/
Valassi, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Manichanh, Chaysavanh (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Amodru, Vincent (Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)) ;
Fernández, Pedro González (Cruces University Hospital, Bilbao) ;
Gaztambide, Sonia (Cruces University Hospital, Bilbao) ;
Yañez, Francisca (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martel-Duguech, Luciana (Hospital de la Santa Creu i Sant Pau) ;
Puig Domingo, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Webb, Susan M. (Universitat Autònoma de Barcelona. Departament de Medicina)
Patients with Cushing's disease (CD) in remission maintain an increased cardiovascular risk. Impaired characteristics of gut microbiome (dysbiosis) have been associated with several cardiometabolic risk factors. [...]
2023 -  10.3389/fendo.2023.1074757
Frontiers in Endocrinology, Vol. 14 (june 2023)
|
|
2024-04-24
04:32 |
|
|
Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment
/
Cantó, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ;
Anguera, Georgia (Hospital de la Santa Creu i Sant Pau) ;
Jiménez, Natalia (Institut d’Investigacions Biomèdiques August Pi i Sunyer) ;
Mellado, Begoña (Institut d’Investigacions Biomèdiques August Pi i Sunyer) ;
Ramírez, Ona (Institut d'Investigació Biomèdica Sant Pau) ;
Mariscal, Anaís (Institut d'Investigació Biomèdica Sant Pau) ;
Maroto Rey, Pablo (Hospital de la Santa Creu i Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona. Departament de Medicina
(1) Background: Prostate cancer is the second most common cancer in men, with androgen suppression as the standard treatment. Despite initially responding to castration, most metastatic prostate cancer patients eventually experience progression. [...]
2023 - 10.3390/diagnostics13132222
Diagnostics, Vol. 13, Num. 13 (june 2023)
|
|
2024-04-24
04:32 |
|
|
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat : a modified Delphi study
/
Bichet, Daniel G. (University of Montréal, Canada) ;
Hopkin, Robert J. (University of Cincinnati College of Medicine, United States) ;
Aguiar, Patrício (Lisbon University) ;
Allam, Sridhar R. (Texas Christian University, Fort Worth, United States) ;
Chien, Yin-Hsiu (National Taiwan University College of Medicine, Taipei, Taiwan) ;
Giugliani, Roberto (Postgraduate Program in Genetics and Molecular Biology (PPGBM) at Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil) ;
Kallish, Staci (University of Pennsylvania, Philadelphia, United States) ;
Kineen, Sabina (Patient Advocate, United States) ;
Lidove, Olivier (French Network of Inherited Metabolic Disorders (G2m), France) ;
Niu, Dau-Ming (National Yang Ming Chiao Tung University, Taipei, Taiwan) ;
Olivotto, Iacopo (Meyer University Children's Hospital, Florence, Italy) ;
Politei, Juan (Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN), Buenos Aires, Argentina) ;
Rakoski, Paul (Patient Advocate, United States) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Tøndel, Camilla (University of Bergen, Norway) ;
Hughes, Derralynn A. (Royal Free London NHS Foundation Trust and University College London, United Kingdom) ;
Universitat Autònoma de Barcelona. Departament de Medicina
Fabry disease is a progressive disorder caused by deficiency of the α-galactosidase A enzyme (α-Gal A), leading to multisystemic organ damage with heterogenous clinical presentation. The addition of the oral chaperone therapy migalastat to the available treatment options for Fabry disease is not yet universally reflected in all treatment guidelines. [...]
2023 - 10.3389/fmed.2023.1220637
Frontiers in Medicine, Vol. 10 (september 2023)
|
|
2024-04-24
04:31 |
|
|
Urban environment and health : a cross-sectional multiregional project based on population health surveys in Spain (DAS-EP project) - study protocol
/
Bereziartua, Ainhoa ;
Cabrera-León, Andrés ;
Subiza-Pérez, Mikel (Bradford Institute for Health Research) ;
Garcia-Baquero Moneo, Gonzalo (Universidad de Salamanca) ;
Delís Gomez, Salvador (Hospital Universitario Araba) ;
Ballester, Ferran (Universitat de València) ;
Estarlich, Marisa ;
Merelles, Antonio ;
Esplugues, Ana ;
Irles, Maria Angeles (General Directorate of Public Health) ;
Barona, Carmen (Universitat de València) ;
Mas, Rosa (Universitat de València) ;
Font-Ribera, Laia (Institut de Recerca Sant Pau) ;
Bartoll, Xavier (Institut de Recerca Sant Pau) ;
Pérez, Katherine (Institut de Recerca Sant Pau) ;
Oliveras, Laura (Institut de Recerca Sant Pau) ;
Binter, Anne-Claire (Universitat Pompeu Fabra) ;
Daponte, Antonio ;
García Mochon, Leticia (Instituto de Investigación Biosanitaria de Granada) ;
García Cortés, Helena ;
Sánchez-Cantalejo Garrido, María del Carmen ;
Lacasaña, Marina (Instituto de Investigación Biosanitaria de Granada) ;
Cáceres, Rocío (Universitat de Sevilla) ;
Rueda, María (Universitat de Granada) ;
Saez, Marc ;
Lertxundi, Aitana ;
Universitat Autònoma de Barcelona
The European Environment Agency estimates that 75% of the European population lives in cities. Despite the many advantages of city life, the risks and challenges to health arising from urbanisation need to be addressed in order to tackle the growing burden of disease and health inequalities in cities. [...]
2024 - 10.1136/bmjopen-2023-074252
BMJ open, Vol. 14 (march 2024)
|
|
2024-04-24
04:31 |
|
2024-04-24
04:31 |
|
|
Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients
/
Escuin i Borràs, Daniel (Institut de Recerca Sant Pau) ;
Bell, Olga (Institut de Recerca Sant Pau) ;
García-Valdecasas Vilanova, Bárbara (Institut de Recerca Sant Pau) ;
Clos Enríquez, Montserrat (Institut de Recerca Sant Pau) ;
Larrañaga, Itziar (Institut de Recerca Sant Pau) ;
López Vilaró, Laura (Institut de Recerca Sant Pau) ;
Mora, Josefina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Andrés, Marta (Institut de Recerca Sant Pau) ;
Arqueros, Cristina (Institut de Recerca Sant Pau) ;
Barnadas i Molins, Agustí (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona
Deregulation of small non-coding RNAs (sncRNAs) has been associated with the onset of metastasis. We evaluated the expression of sncRNAs in patients with early-stage breast cancer, performing RNA sequencing in 60 patients for whom tumor and sentinel lymph node (SLN) samples were available, and conducting differential expression, gene ontology, enrichment and survival analyses. [...]
2024 - 10.3390/ijms25073982
International journal of molecular sciences, Vol. 25 (april 2024)
|
|
2024-04-24
04:31 |
|
|
Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis : A Randomized Double-Blind Controlled Trial
/
Ayats-Vidal, Roser (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Bosque, Montserrat (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Cordobilla, Begoña (Universitat de Barcelona) ;
Asensio-De la Cruz, Oscar (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
García-González, Miguel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Loureda-Pérez, Susana (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Fernández-López, Elena (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Robert-Barriocanal, Eva (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Valiente-Planas, Andrea (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Domingo, Joan Carles (Universitat de Barcelona) ;
Universitat Autònoma de Barcelona
A randomized, double-blind, and placebo-controlled study was conducted to assess the effect of dietary supplementation with high-rich docosahexaenoic acid (DHA) (Tridocosahexanoin-AOX ® 70%) at 50 mg/kg/day in pediatric patients with cystic fibrosis (CF) as compared with placebo. [...]
2024 - 10.3390/nu16070970
Nutrients, Vol. 16 (march 2024)
|
|
2024-04-24
04:31 |
|
|
Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction
/
Amor-Salamanca, Almudena (Health in Code SL) ;
Santana Rodríguez, Alfredo (Universidad de Las Palmas de Gran Canaria) ;
Rasoul, Hazhee (St. Bartholomew's Hospital) ;
Rodríguez-Palomares, José F. (Hospital Universitari Vall d'Hebron) ;
Moldovan, Oana (Centro Hospitalar Universitário Lisboa Norte) ;
Hey, Thomas Morris (Odense University Hospital) ;
Delgado, María Gallego (Instituto de Salud Carlos III) ;
Cuenca, David López (Hospital Clínico Universitario Virgen de la Arrixaca) ;
de Castro Campos, Daniel (Hospital Universitario Puerta de Hierro) ;
Basurte-Elorz, María Teresa (Complejo Hospitalario de Navarra) ;
Macías-Ruiz, Rosa (Instituto de Investigación Biosanitaria de Granada) ;
Fuentes Cañamero, María Eugenia (Hospital Universitario de Badajoz) ;
Galvin, Joseph (University College Dublin School of Medicine) ;
Bilbao Quesada, Raquel (Hospital Álvaro Cunqueiro) ;
de la Higuera Romero, Luis (Health in Code SL) ;
Trujillo-Quintero, Juan Pablo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
García-Cruz, Loida María (Universidad de Las Palmas de Gran Canaria) ;
Cárdenas-Reyes, Ivonne (Health in Code SL) ;
Jiménez-Jáimez, Juan (Hospital Universitario Virgen de las Nieves) ;
García-Hernández, Soledad (Hospital Universitario San Cecilio) ;
Valverde-Gómez, María (Hospital Universitario 12 de Octubre) ;
Gómez-Díaz, Iria (Health in Code SL) ;
Limeres Freire, Javier (Hospital Universitari Vall d'Hebron) ;
García-Pinilla, José Manuel (Universidad de Málaga) ;
Gimeno-Blanes, Juan R. (Hospital Clínico Universitario Virgen de la Arrixaca) ;
Savattis, Konstantinos (Queen Mary University of London) ;
García-Pavía, Pablo (Centro Nacional de Investigaciones Cardiovasculares) ;
Ochoa, Juan Pablo (Centro Nacional de Investigaciones Cardiovasculares) ;
Universitat Autònoma de Barcelona
Less than 40% of patients with dilated cardiomyopathy (DCM) have a pathogenic/likely pathogenic genetic variant identified. TBX20 has been linked to congenital heart defects; although an association with left ventricular noncompaction (LVNC) and DCM has been proposed, it is still considered a gene with limited evidence for these phenotypes. [...]
2024 - 10.1161/CIRCGEN.123.004404
Circulation. Genomic and Precision Medicine, Vol. 17 (february 2024) , p. e004404
|
|
2024-04-24
04:31 |
|
2024-04-23
06:32 |
|
|
Del lado de acá. Una revisión desde Europa de la expedición tripartita a México (1861-1862)
/
Santirso Rodríguez, Manuel (Universitat Autònoma de Barcelona. Departament d'Història Moderna i Contemporània)
El desenlace de la expedición hispano-franco-británica a México de 1861-1862 ha sido explicado a menudo como consecuencia de decisiones individuales, sobre todo las del general español Juan Prim. [...]
The outcome of the Spanish-Franco-British expedition to Mexico in 1861-1862 has often been explained as a consequence of individual decisions, especially those of the Spanish General Juan Prim. However, the withdrawal of the contingent under his command has been foreseen in advance in the guidelines of his Government, presided by Leopoldo O'Donnell and with Saturnino Calderón Collantes as Minister of Foreign Affairs. [...]
2024 - 10.1387/hc.23517
Historia contemporánea, Núm. 75 (2024) , p. 471-501
|
|
|
|
guest ::
